578 related articles for article (PubMed ID: 31210295)
1. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
Li YM; Li XJ; Yang HL; Zhang YB; Li JC
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-486 inhibits cell proliferation, invasion and migration via down-regulating the TENM1 expressions and affecting ERK and Akt signaling pathways and epithelial-to-mesenchymal transition in papillary thyroid carcinoma.
Sun YH; Liu ZF; Yang BB; Yu B
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8429-8439. PubMed ID: 31646573
[TBL] [Abstract][Full Text] [Related]
3. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.
Wang Y; Liu BG; Zhou CX
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337
[TBL] [Abstract][Full Text] [Related]
5. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.
Teng P; Jiao Y; Hao M; Tang X
J Cell Biochem; 2018 Jul; 119(7):5243-5252. PubMed ID: 29236322
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-760 inhibits the biological progression of colorectal carcinoma by directly targeting FOXA1 and regulating epithelial-to-mesenchymal transition and PI3K/AKT signaling pathway.
Cong K; Li CG; Wei YH; Zhang K; Xu HB
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5730-5740. PubMed ID: 31298352
[TBL] [Abstract][Full Text] [Related]
7. MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer.
Zhang L; Liu XL; Yuan Z; Cui J; Zhang H
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4663-4672. PubMed ID: 31210292
[TBL] [Abstract][Full Text] [Related]
8. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway.
Liu H; Zhang L; Ding X; Sui X
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
[TBL] [Abstract][Full Text] [Related]
9. Association of the TLR4-MyD88-JNK signaling pathway with inflammatory response in intracranial hemorrhage rats and its effect on neuronal apoptosis.
Huang DJ; Li Y; Yang ZX; Sun YN; Wan D
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4882-4889. PubMed ID: 31210322
[TBL] [Abstract][Full Text] [Related]
10. Targeting EZH2 by microRNA-449a inhibits osteosarcoma cell proliferation, invasion and migration via regulation of PI3K/AKT signaling pathway and epithelial-mesenchymal transition.
Lu DG; Tang QL; Wei JH; He FY; Lu L; Tang YJ
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1656-1665. PubMed ID: 32141531
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis.
Liu X; Xie S; Zhang J; Kang Y
Cancer Biother Radiopharm; 2020 Nov; 35(9):640-649. PubMed ID: 32191528
[No Abstract] [Full Text] [Related]
12. MicroRNA-218 regulates the epithelial-to-mesenchymal transition and the PI3K/Akt signaling pathway to suppress lung adenocarcinoma progression by directly targeting BMI-1.
Xu L; Sun HB; Xu ZN; Han XL; Yin YY; Zheng Y; Zhao Y; Wang ZX
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7978-7988. PubMed ID: 31599423
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of long non-coding RNA DUXAP8 suppresses proliferation, metastasis and EMT by modulating miR-498 through TRIM44-mediated AKT/mTOR pathway in non-small-cell lung cancer.
Ji X; Tao R; Sun LY; Xu XL; Ling W
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3152-3165. PubMed ID: 32271433
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-199a Inhibits Cell Proliferation, Migration, and Invasion and Activates AKT/mTOR Signaling Pathway by Targeting B7-H3 in Cervical Cancer.
Yang X; Feng KX; Li H; Wang L; Xia H
Technol Cancer Res Treat; 2020; 19():1533033820942245. PubMed ID: 32856542
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1.
Shi C; Zhang Z
Oncol Rep; 2017 Jan; 37(1):501-509. PubMed ID: 27878258
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway.
Wu YC; Li SY; Jia YF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8940-8949. PubMed ID: 31696481
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-489 targets XIAP to inhibit the biological progression of ovarian cancer via regulating PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
Jiang HW; Li L; Jiang P; Wang YF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4113-4122. PubMed ID: 32373947
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway.
Xiao R; Wang H; Yang B
Bioengineered; 2021 Dec; 12(2):10596-10607. PubMed ID: 34895048
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA
Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
[TBL] [Abstract][Full Text] [Related]
20. MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K/AKT signaling pathway.
Zhang L; Wang CZ; Ma M; Shao GF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8813-8822. PubMed ID: 31696468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]